Evidence map›Paper›PMID 25190759›Full record

ReviewBritish medical bulletin2014

Non-communicable diseases in South Asia: contemporary perspectives.

Karen R Siegel, Shivani A Patel, Mohammed K Ali

Open access · bronzeAbstract readReview
In one paragraph

Review in British medical bulletin, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 6 pooled it
12.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 6 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Karen R SiegelHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
Shivani A PatelHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
Mohammed K AliHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA mkali@emory.edu.
Emory University · US

Funding

Nutrition Sciences and HealthT32DK007734 · NIDDK · EMORY UNIVERSITY · PI RAMAKRISHNAN, USHA · 1997 to 2016
$2.5M
NIDDK NIH HHS T32 DK007734
6 · The paper itself

Abstract

introductionNon-communicable diseases (NCDs) such as metabolic, cardiovascular, cancers, injuries and mental health disorders are increasingly contributing to the disease burden in South Asia, in light of demographic and epidemiologic transitions in the region. Home to one-quarter of the world's population, the region is also an important priority area for meeting global health targets. In this review, we describe the current burden of and trends in four common NCDs (cardiovascular disease, diabetes, cancer and chronic obstructive pulmonary disease) in South Asia. SOURCES OF DATA: The 2010 Global Burden of Disease Study supplemented with the peer-reviewed literature and reports by international agencies and national governments. AREAS OF AGREEMENT: The burden of NCDs in South Asia is rising at a rate that exceeds global increases in these conditions. Shifts in leading risk factors-particularly dietary habits, tobacco use and high blood pressure-are thought to underlie the mounting burden of death and disability due to NCDs. Improvements in life expectancy, increasing socioeconomic development and urbanization in South Asia are expected to lead to further escalation of NCDs. AREAS OF CONTROVERSY: Although NCD burdens are currently largest among affluent groups in South Asia, many adverse risk factors are concentrated among the poor, portending a future increase in disease burden among lower income individuals. GROWING POINTS: There continues to be a notable lack of national surveillance data to document the distribution and trends in NCDs in the region. Similarly, economic studies and policy initiatives addressing NCD burdens are still in their infancy. AREAS TIMELY FOR DEVELOPING RESEARCH: Opportunities for innovative structural and behavioral interventions that promote maintenance of healthy lifestyles-such as moderate caloric intake, adequate physical activity and avoidance of tobacco-in the context of socioeconomic development are abundant. Testing of health care infrastructure and systems that best provide low-cost and effective detection and treatment of NCDs is a priority for policy researchers.

Indexed as

Asia, WesternCardiovascular DiseasesCost of IllnessDiabetes MellitusHumansNeoplasmsPulmonary Disease, Chronic ObstructiveRisk Factorscancerscardiovascular diseaseschronic obstructive pulmonary diseasediabetesnon-communicable diseaseSouth Asia

Identifiers

PMID25190759
PMCPMC4416117
OpenAlexW2168142718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.